IECIE 2022: Global Exhibition for Electronic Cigarette Industry

Oct.19.2022
IECIE 2022: Global Exhibition for Electronic Cigarette Industry
The 2022 Shenzhen International Electronic Cigarette Industry Expo (IECIE) will be held in Jakarta from 20-22 Oct 2022.

The 2022 Shenzhen International Electronic Cigarette Industry Expo (IECIE) will be held from October 20th to 22nd, 2022. As a member of the esteemed British Informa Group, IECIE is a globally influential exhibition platform in the vertical field of electronic cigarettes. With its long-standing global perspective and abundant resources of domestic and foreign exhibitors and professional buyers, IECIE has decided to take an important step with its exhibitors and partners: IECIE 2022 will officially move overseas and complete its overall layout from Asia to the United States and Europe within three years.


The exhibition will be held at the Jakarta International Expo Center, with an expected exhibition area of 22,000 square meters and an estimated turnout of 25,000 visitors. The number of participating businesses and brand offerings is projected to reach 400.


As a global electronic cigarette exhibition, this event covers the upstream accessory supply chain of the electronic cigarette industry, as well as downstream finished equipment and e-commerce solutions. It serves as a platform for showcasing and promoting global electronic cigarette technology and brands. It will cover Asia and Europe and will become an important link connecting global markets.


The exhibition will feature famous domestic and international electronic cigarette brands such as Yueke, FEELM, Youzi, LaiMi, JUSTFOG and more. Several electronic cigarette brand merchants are currently setting up their exhibition booths.


2FIRSTS will set up a media broadcast room at the exhibition site to provide full coverage of the event. Their on-site staff will have exclusive interviews with heavyweight guests and well-known industry figures, obtaining the latest updates in the Southeast Asian market. This will help Chinese companies access the latest market information and expand their reach into the Southeast Asian market.


Statement


1. This article is intended solely for internal discussion and communication within the industry and does not promote or recommend any specific brands or products. 2. Smoking is harmful to health. Minors are prohibited from reading this article.


This article is an original piece written by Shenzhen 2FIRSTS Technology Co., Ltd. The copyright and permission to use belong to the company and no individual or organization is permitted to copy, reproduce, or use in any other way without authorization. Any violation of the company's copyright will result in legal action.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Photo Gallery | A Sneak Peek at the World Vape Show: What Products Are Major Brands Betting On?
Photo Gallery | A Sneak Peek at the World Vape Show: What Products Are Major Brands Betting On?
The World Vape Show will take place in Dubai from June 18 to 20. Ahead of the event, several brands have shared teasers of new products and technologies online. 2Firsts has compiled a selection of these previews for readers.
Jun.12 by 2FIRSTS.ai
MGH Study: Varenicline Boosts Young Adults’ E-Cigarette Quit Rates by 50%
MGH Study: Varenicline Boosts Young Adults’ E-Cigarette Quit Rates by 50%
A study by Massachusetts General Hospital found that the oral smoking cessation drug varenicline significantly improves e-cigarette quit rates among young people aged 16 to 25. In a 12-week trial, 50% of participants in the varenicline group successfully quit vaping, compared to just 14% in the placebo group. After six months, 28% of those in the treatment group remained vape-free.
Apr.24 by 2FIRSTS.ai
FDA Requests Laid-Off Employees Back to Help with Tobacco Cases, Enforcement Capacity Severely Weakened
FDA Requests Laid-Off Employees Back to Help with Tobacco Cases, Enforcement Capacity Severely Weakened
FDA staff cuts impact tobacco enforcement: HHS layoffs jeopardize fines on retailers, potentially hindering tobacco law enforcement.
Apr.17 by 2FIRSTS.ai
German Court: ELFPRO Infringed ELFBAR Trademark; Offender to Cease Operations
German Court: ELFPRO Infringed ELFBAR Trademark; Offender to Cease Operations
The Düsseldorf Regional Court ruled that the use of "ELFPRO" infringed on ELFBAR's trademark. The court supported iMiracle’s claims during the interim injunction phase. The infringing party plans to cease operations under legal pressure.
Apr.29 by 2FIRSTS.ai
US Media Exposes Miami E-Cig Expo Overrun with Illegal Products, Ex-Official Decries "No Consequences" for Illegality
US Media Exposes Miami E-Cig Expo Overrun with Illegal Products, Ex-Official Decries "No Consequences" for Illegality
Despite a federal ban on flavored vapes aimed at curbing youth addiction, these illegal products were openly displayed and sold at public expos across the United States, as discovered at a recent event in Miami.
Apr.22
U.S. ITC Reopens PAX Labs Case Against STIIIZY, ALD; Domestic Industry Status at Center of Dispute
U.S. ITC Reopens PAX Labs Case Against STIIIZY, ALD; Domestic Industry Status at Center of Dispute
The U.S. International Trade Commission (ITC) has announced a partial review of a key ruling in PAX Labs' patent infringement case against STIIIZY and ALD, focusing on whether the economic prong of the "domestic industry" requirement was properly assessed. While the commission previously found some of PAX's patents valid and infringed, it ruled that PAX had not demonstrated sufficient U.S. economic investment to establish a domestic industry, and therefore did not find a violation.
May.20 by 2FIRSTS.ai